Orion’s VP Drug Discovery Presenting at Undruggable Leaders Forum
We are looking forward to the Undruggable Leaders Forum to be held September 15th-16th. It is a virtual conference this year with the purpose of ‘Uniting the Pioneers of
Precision Engineering GPCR-Targeted Therapeutics
Orion Biotechnology is a clinical stage biotechnology company discovering and developing next-generation G Protein-Coupled Receptor (GPCR)-targeted therapeutics for the treatment of cancer and other serious diseases.
A Break Through Science & Technology Platform
We precision-engineer natural peptide and protein analogs that bind to GPCR targets with both enhanced potency and tailored signaling activity. This novel scientific approach is enabled by Orion’s proprietary drug discovery platform and has produced a growing pipeline of drug candidates that effectively target GPCRs implicated across therapeutic areas of high unmet need.
CCR5 Inhibitor Program
Orion’s lead compound, OB-002, is a chemokine analog of CCL5 with best-in-class potency and a proven mechanism of action shown to have broad applicability across a range of serious diseases, including Cancer, Neuroinflammation and HIV.
Recognized
Leadership
Previous
Next
Orion Adds Industry Leader to Board
September 1, 2021
Ottawa, Canada, Aug. 31, 2021 (GLOBE NEWSWIRE) — Orion Biotechnology, a clinical stage company that is developing novel G Protein-Coupled Receptor (GPCR)-targeted therapeutics for the treatment of cancer and other
Orion Biotechnology Secures $11.5M Series A Financing
June 18, 2021
Ottawa, Canada [June 17, 2021]: Orion Biotechnology Canada Ltd., a clinical-stage biotechnology company, today announced that it has raised $11.5M USD in a Series A financing. The oversubscribed round was led
Orion Biotechnology Adds Four Experts to its Scientific Advisory Board
April 14, 2021
Ottawa, Canada, April 13, 2021 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd., a clinical stage biotechnology company focused on precision engineering small protein therapeutics, today announced the addition of four experts
Global Headquarters
343 Preston Street
11th floor,
Ottawa, On K1S 1N4
CANADA
+1 343.291.1032
Switzerland
Campus Biotech
Innovation Park
Avenue de Sécheron 15
1202 Genève
SWITZERLAND
Poland
Orion Biotechnology
Life Science Park
UI Bobrzyńskiego 14
30-348 Krakôw
POLAND
